AUTHOR=Ren Beibei , Chen Yu , Bai Xuanye , Zheng Jiawen , Chang Jing , Jiang Xiangnan , Xia Qingxin , Zhang He 

TITLE=Case report: Clinicopathological and molecular characteristics of pediatric-type follicular lymphoma

JOURNAL=Frontiers in Pediatrics

VOLUME=Volume 11 - 2023

YEAR=2023

URL=https://www.frontiersin.org/journals/pediatrics/articles/10.3389/fped.2023.1205384

DOI=10.3389/fped.2023.1205384

ISSN=2296-2360

ABSTRACT=<p>Pediatric-type follicular lymphoma (PTFL) is a rare pediatric-type indolent B-cell lymphoma that clinicopathologically differs from adult lymphoma. Accurate diagnosis of PTFL, which is often challenging, is essential to avoid missed diagnosis, misdiagnosis, and overtreatment. To improve our understanding of PTFL, clinicopathological features, differential diagnosis, and molecular mutation characteristics of four patients of PTFL were analyzed using hematoxylin and eosin staining, immunohistochemistry, polymerase chain reaction, fluorescence <italic>in situ</italic> hybridization (FISH), and next-generation sequencing (NGS). A relevant literature review was also performed. All four PTFL patients were male, with ages of 6, 18, 13, and 15 years, and had St. Jude stage I or III. Microscopic results showed that the structure of the lymph nodes was destroyed; the tumor follicles were enlarged and irregular; medium–large blastoid cells with a consistent shape were visible in tumor follicles, and the nucleus was round or oval; and the “starry sky” pattern was easily observed. Tumor cells expressed CD20, PAX-5, BCL6, and CD10. None of the tumor cells expressed BCL2, CD3, CD5, MUM1, and CyclinD1. CD21 showed dilated growth of a follicular dendritic cell network in tumor follicles. EBER genes were negative in all cases. FISH testing also showed negative <italic>BCL2</italic> gene breaks and <italic>IRF4</italic> gene breaks in all cases. NGS detected 12 related mutant genes, including <italic>KMT2D</italic>, <italic>CD79B</italic>, <italic>GNA13</italic>, <italic>MYD88</italic>, <italic>PCLO</italic>, <italic>TCF3</italic>, <italic>IRF8</italic>, <italic>MAP2K1</italic>, <italic>FOXO1</italic>, <italic>POLE</italic>, <italic>INPP5D</italic>, and <italic>FAT4</italic>. Two of the four patients had an <italic>IRF8</italic> gene mutation, and one patient had a dual mutation of the <italic>MAP2K1</italic> gene. Our study revealed the unique clinicopathological features and molecular mutational characteristics of PTFL, consolidated our understanding of PTFL, and identified other rare mutant genes, which may further contribute to the study of the molecular mechanism and differential diagnosis of PTFL.</p>